Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)

Funding Opportunity PAR-16-020 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support clinical studies that will fill gaps in the design of upcoming clinical trials in rare neurological or neuromuscular diseases by validating clinical outcome measures or biomarkers, or by characterizing cohorts of relevant patients.Through the support of trial readiness studies, NINDS expects to accelerate the initiation of clinical trials for rare diseases and to increase the likelihood of success in those trials.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding